Market Position CENTERVUE is part of Revenio Group, a global ophthalmic diagnostics leader with a broad installed base and international reach. This suggests potential for cross-sell of Centervue imaging solutions and leverage of Revenio’s distribution network to accelerate geographic expansion.

Expansion Levers The company has a US subsidiary established since 2012 and revenue signals are modest, indicating growth opportunities in North America through updated imaging platforms, service contracts, and training programs to drive adoption in clinics and hospitals.

Product Fit Centervue’s automated, internet-connected ocular imaging devices align with demand for high-tech, remote-monitoring capable diagnostics. Target clinics investing in glaucoma, diabetic retinopathy, and macular degeneration workflows for improved efficiency and tele-diagnostics.

Partner with Revenio As part of Revenio Group, there is potential to bundle Centervue imaging with Icare tonometers and other eye-diagnostic products, enabling multi-product sales to ophthalmology practices and hospital systems seeking integrated solutions.

Growth Signals R&D investment is ongoing within the Revenio ecosystem, presenting an opportunity to position Centervue as a source of cutting-edge imaging technology in pitches about future-ready ophthalmic diagnostics and long-term device modernization programs.